financetom
Business
financetom
/
Business
/
Deutsche Bank Comments on UK's GDP Data Cooling Faster Than Expected
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Deutsche Bank Comments on UK's GDP Data Cooling Faster Than Expected
Nov 15, 2024 12:23 PM

06:34 AM EST, 11/15/2024 (MT Newswires) -- The United Kingdom's gross domestic product Friday missed expectations for Q3 as after a sizzling start, GDP simmered over summer, slowing to a paltrier 0.1% quarter over quarter, said Deutsche Bank's Chief UK Economist Sanjay Raja.

Despite strength in household spending of 0.5% quarter over quarter, business investment of 1.2% quarter over quarter, government consumption of 0.6% quarter over quarter and net trade, GDP was dragged lower by more volatile bits of the gross fixed capital formation bucket -- including net acquisitions, which fell by 96% quarter over quarter.

September GDP also missed expectations, shrinking by 0.1% month over month, pointed out Raja.

Both data points will act as a drag to Q4 2024 GDP and 2024 GDP growth more generally, the bank's economist stated.

The road ahead remains "bumpy," added Raja. Budget tax measures -- particularly the employer National Insurance Contributions increase -- could start to hit business sentiment in Q4 2024 and Q1 2025 before any fiscal stimulus kicks in. Private sector investment plans may start to get trimmed.

Hiring plans are likely to be put on ice. Indeed, cracks in the labor market are already emerging. Deutsche Bank sees growth picking up a touch towards year-end.

Deutsche Bank still estimates positive momentum into 2025. But downside risks are brewing. Geopolitical risks are on the rise with the spectre of a trade war looming. For now, however, Raja remains optimistic about the path ahead with underlying momentum remaining at, or around, the trend.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA approves Biocon unit's biosimilar to blockbuster eye drug Eylea
US FDA approves Biocon unit's biosimilar to blockbuster eye drug Eylea
May 20, 2024
May 20 (Reuters) - The U.S. Food and Drug Administration on Monday approved Biocon unit's biosimilar to Regeneron Pharmaceuticals' ( REGN ) blockbuster eye drug Eylea, according to information on the agency's website. ...
Guidewire's InsuranceNow Platform Chosen by United Heritage to Modernize Operations
Guidewire's InsuranceNow Platform Chosen by United Heritage to Modernize Operations
May 20, 2024
10:32 AM EDT, 05/20/2024 (MT Newswires) -- Guidewire Software's ( GWRE ) InsuranceNow platform has been selected by United Heritage Insurance to modernize its operations, the companies said Monday. United Heritage's property and casualty insurance arms, Sublimity Insurance and United Heritage Property and Casualty, plan to implement InsuranceNow by line of business, the companies said. Financial details weren't disclosed. Price:...
Orion Group Files for $150 Million Mixed Shelf
Orion Group Files for $150 Million Mixed Shelf
May 20, 2024
10:30 AM EDT, 05/20/2024 (MT Newswires) -- Orion Group Holdings ( ORN ) on Monday filed a registration statement covering the potential sale of up to $150 million of its securities. The filing covers the potential sale of common stock, preferred stock, warrants and rights. Net proceeds from the potential sale will be used for general corporate purposes, including working...
Esperion Therapeutics Says Primary Endpoint Achieved in Hypercholesterolemia Treatment Phase 3 Trial; Shares Rise
Esperion Therapeutics Says Primary Endpoint Achieved in Hypercholesterolemia Treatment Phase 3 Trial; Shares Rise
May 20, 2024
10:30 AM EDT, 05/20/2024 (MT Newswires) -- Esperion Therapeutics ( ESPR ) and Otsuka Pharmaceutical said Monday that a phase 3 trial in Japan for bempedoic acid as a potential treatment for hypercholesterolemia achieved its primary endpoint. The preliminary results showed that the percentage change from baseline in LDL cholesterol at week 12, the primary endpoint, was negative 25.25%% in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved